Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kathryn A. Zug is active.

Publication


Featured researches published by Kathryn A. Zug.


Dermatitis | 2004

North American Contact Dermatitis Group patch-test results, 2001-2002 study period.

Melanie D. Pratt; Donald V. Belsito; Vincent A. DeLeo; Joseph F. Fowler; Anthony F. Fransway; Howard I. Maibach; James G. Marks; C. G. Toby Mathias; Robert L. Rietschel; Denis Sasseville; Elizabeth F. Sherertz; Frances J. Storrs; James S. Taylor; Kathryn A. Zug

Background: Allergic contact dermatitis is a significant cause of cutaneous disease affecting many individuals in the home and at the workplace. Patch testing is the most worthwhile diagnostic tool for the evaluation of patients with suspected allergic contact dermatitis. Objective: This study reports the results of patch testing from January 1, 2001, to December 31, 2002, by the North American Contact Dermatitis Group (NACDG). Methods: Patients were tested with an extended screening series of 65 allergens. A standardized patch‐testing technique was used. Data from these patients were recorded on a standardized computer entry form and analyzed. Results: Sixty‐five allergens were tested on 4,913 patients. The top 10 allergens remain the same in this study period as in the 1999‐2000 study period: nickel sulfate (16.7%), neomycin (11.6%), Myroxilon pereirae (balsam of Peru) (11.6%), fragrance mix (10.4%), thimerosal (10.2%), sodium gold thiosulfate (10.2%), quaternium‐15 (9.3%), formaldehyde (8.4%), bacitracin (7.9%), and cobalt chloride (7.4%). Of the 4,913 patients tested, 69% had at least one positive allergic patch‐test reaction. Of all patients, 15.8% had occupation‐related dermatitis; 15.4% were determined to have irritant contact dermatitis, and 11.1% of the 15.4% had a relevant reaction to an occupational irritant. Of all patients tested, 16.7% had a relevant reaction to an allergen not in the NACDG standard series, and 5.5% had a relevant reaction to an occupational allergen not in the standard series. Conclusion: Our findings once again reinforce the need for a more comprehensive group of diagnostic allergens than those found in the standard screening kits. The usefulness of patch testing is enhanced when a greater number of allergens are tested, especially nonstandard allergens occupationally encountered.


Dermatitis | 2009

Patch-test results of the North American Contact Dermatitis Group 2005-2006.

Kathryn A. Zug; Warshaw Em; Joseph F. Fowler; Howard I. Maibach; Belsito Dl; Pratt; Denis Sasseville; Storrs Fj; James S. Taylor; Mathias Cg; Vincent A. DeLeo; Robert L. Rietschel; James G. Marks

Background The North American Contact Dermatitis Group (NACDG) tests patients who have suspected allergic contact dermatitis with a broad series of screening allergens, and publishes periodic reports of its data. Objective To report the NACDG patch‐test results from January 1, 2005, to December 31, 2006, and to compare results to pooled test data from the previous 10 years. Methods Standardized patch testing with 65 allergens was used at 13 centers in North America. Chi‐square statistics were utilized for comparisons with previous NACDG data. Results NACDG patch‐tested 4,454 patients; 12.3% (557) had an occupation‐related skin condition, and 65.3% (2,907) had at least one allergic patch‐test reaction. The 15 most frequently positive allergens were nickel sulfate (19.0%), Myroxilon pereirae (balsam of Peru, 11.9%), fragrance mix I (11.5%), quaternium‐15 (10.3%), neomycin (10.0%), bacitracin (9.2%), formaldehyde (9.0%), cobalt chloride (8.4%), methyldibromoglutaronitrile/phenoxyethanol (5.8%), p‐phenylenediamine (5.0%), potassium dichromate (4.8%), carba mix (3.9%), thiuram mix (3.9%), diazolidinylurea (3.7%), and 2‐bromo‐2‐nitropropane‐1,3‐diol (3.4%). As compared to the 1994‐2004 data, there were significant increases in rates of positivity to nickel, quaternium‐15, potassium dichromate, lidocaine, and tea tree oil. Of patch‐tested patients, 22.9% (1,019) had a relevant positive reaction to a supplementary allergen; 4.9% (219) had an occupationally relevant positive reaction to a supplementary allergen. Conclusion Nickel has been the most frequently positive allergen detected by the NACDG; rates significantlyincreased in the current study period and most reactions were clinically relevant. Other common allergens were topical antibiotics, preservatives, fragrance mix I and paraphenylenediamine. Testing with an expanded allergen series and supplementary allergens enhances detection of relevant positive allergens.


Dermatitis | 2013

North American Contact Dermatitis Group patch test results: 2009 to 2010.

Erin M. Warshaw; Donald V. Belsito; James S. Taylor; Denis Sasseville; Joel G. DeKoven; Matthew J. Zirwas; Anthony F. Fransway; C. G. Toby Mathias; Kathryn A. Zug; Vincent A. DeLeo; Joseph F. Fowler; James G. Marks; Melanie D. Pratt; Frances J. Storrs; Howard I. Maibach

Background Patch testing is an important diagnostic tool for determination of substances responsible for allergic contact dermatitis. Objective This study reports the North American Contact Dermatitis Group (NACDG) patch testing results from January 1, 2009, to December 31, 2010. Methods At 12 centers in North America, patients were tested in a standardized manner with a screening series of 70 allergens. Data were manually verified and entered into a central database. Descriptive frequencies were calculated, and trends were analyzed using &khgr;2 statistics. Results A total of 4308 patients were tested. Of these, 2614 (60.7%) had at least 1 positive reaction, and 2284 (46.3%) were ultimately determined to have a primary diagnosis of allergic contact dermatitis. Four hundred twenty-seven (9.9%) patients had occupationally related skin disease. There were 6855 positive allergic reactions. As compared with the previous reporting period (2007–2008), the positive reaction rates statistically decreased for 20 allergens (nickel, neomycin, Myroxylon pereirae, cobalt, formaldehyde, quaternium 15, methydibromoglutaronitrile/phenoxyethanol, methylchlorisothiazolinone/methylisothiazolinone, potassium dichromate, diazolidinyl urea, propolis, dimethylol dimethylhydantoin, 2-bromo-2-nitro-1,3-propanediol, methyl methacrylate, ethyl acrylate, glyceryl thioglycolate, dibucaine, amidoamine, clobetasol, and dimethyloldihydroxyethyleneurea; P < 0.05) and statistically increased for 4 allergens (fragrance mix II, iodopropynyl butylcarbamate, propylene glycol, and benzocaine; P < 0.05). Approximately one quarter of tested patients had at least 1 relevant allergic reaction to a non-NACDG allergen. Hypothetically, approximately one quarter of reactions detected by NACDG allergens would have been missed by TRUE TEST (SmartPractice Denmark, Hillerød, Denmark). Conclusions These results affirm the value of patch testing with many allergens.


Contact Dermatitis | 2015

North American contact dermatitis group patch test results: 2011-2012.

Erin M. Warshaw; Howard I. Maibach; James S. Taylor; Denis Sasseville; Joel G. DeKoven; Matthew J. Zirwas; Anthony F. Fransway; C. G. Toby Mathias; Kathryn A. Zug; Vincent A. DeLeo; Joseph F. Fowler; James G. Marks; Melanie D. Pratt; Frances J. Storrs; Donald V. Belsito

BackgroundPatch testing is an important diagnostic tool for assessment of allergic contact dermatitis (ACD). ObjectiveThis study documents the North American Contact Dermatitis Group (NACDG) patch-testing results from January 1, 2011, to December 31, 2012. MethodsAt 12 centers in North America, patients were tested in a standardized manner with a series of 70 allergens. Data were manually verified and entered into a central database. Descriptive frequencies were calculated, and trends analyzed using &khgr;2 statistics. ResultsFour thousand two hundred thirty-eight patients were tested; of these, 2705 patients (63.8%) had at least 1 positive reaction, and 2029 (48.0%) were ultimately determined to have a primary diagnosis of ACD. Four hundred eight patients (9.6%) had occupationally related skin disease. There were 7532 positive allergic reactions. As compared with previous reporting periods (2009–2010 and 2000–2010), positive reaction rates statistically increased for 6 allergens: methylchloroisothiazolinone/methylisothiazolinone (5.0%; risk ratios [RRs]: 2.01 [1.60–2.52], 1.87 [1.61–2.18]), lanolin alcohol (4.6%; RRs 1.83 [1.45–2.30], 2.10 [1.79–2.47]), cinnamic aldehyde (3.9%; 1.69 [1.32–2.15], 1.53 [1.28–1.82]), glutaral (1.5%; 1.67 [1.13–2.48], 1.31 [1.00–1.71]), paraben mix (1.4%; 1.77 [1.16–2.69], 1.44 [1.09–1.92]), and fragrance mix I (12.1%; RRs 1.42 [1.25–1.61], 1.24 [1.14–1.36]). Compared with the previous decade, positivity rates for all formaldehyde-releasing preservatives significantly decreased (formaldehyde 6.6%; RR, 0.82 [0.73, 0.93]; quaternium-15 6.4% RR 0.75 [0.66, 0.85]; diazolidinyl urea 2.1%; RR, 0.67 [0.54, 0.84]; imidazolidinyl urea 1.6%, 0.60 [0.47, 0.77]; bronopol 1.6%; RR, 0.60 [0.46, 0.77]; DMDM hydantoin 1.6%; RR, 0.59 [0.54, 0.84]). Approximately a quarter of patients had at least 1 relevant allergic reaction to a non-NACDG allergen. In addition, approximately one-fourth to one-third of reactions detected by NACDG allergens would have been hypothetically missed by T.R.U.E. TEST (SmartPractice Denmark, Hillerød, Denmark). ConclusionsThese data document the beginning of the epidemic of sensitivity to methylisothiazolinones in North America, which has been well documented in Europe. Patch testing with allergens beyond a standard screening tray is necessary for complete evaluation of occupational and nonoccupational ACD.


Dermatitis | 2013

North American Contact Dermatitis Group patch test results for 2007-2008.

Anthony F. Fransway; Kathryn A. Zug; Donald V. Belsito; Vincent A. DeLeo; Joseph F. Fowler; Howard I. Maibach; James G. Marks; C. G. Toby Mathias; Melanie D. Pratt; Robert L. Rietschel; Denis Sasseville; Frances J. Storrs; James S. Taylor; Erin M. Warshaw; Joel G. DeKoven; Matthew J. Zirwas

BackgroundThe North American Contact Dermatitis Group (NACDG) tests patients with suspected allergic contact dermatitis to a broad series of screening allergens and publishes periodic reports. ObjectiveThe aims of this study were to report the NACDG patch-testing results from January 1, 2007, to December 31, 2008, and to compare results to pooled test data from the previous 2 and 10 years to analyze trends in allergen sensitivity. Methods and MaterialsStandardized patch testing with 65 allergens was used at 13 centers in North America. &khgr;2 analysis was used for comparisons. ResultsA total of 5085 patients were tested; 11.8% (598) had an occupationally related skin condition, and 65.3% (3319) had at least 1 allergic patch test reaction, which is identical to the NACDG data from 2005 to 2006. The top 15 most frequently positive allergens were nickel sulfate (19.5%), Myroxylon pereirae (11.0%), neomycin (10.1%), fragrance mix I (9.4%), quaternium-15 (8.6%), cobalt chloride (8.4%), bacitracin (7.9%), formaldehyde (7.7%), methyldibromoglutaronitrile/phenoxyethanol (5.5%), p-phenylenediamine (5.3%), propolis (4.9%), carba mix (4.5%), potassium dichromate (4.1%), fragrance mix II (3.6%), and methylchloroisothiazolinone/methylisothiazolinone (3.6%). There were significant increases in positivity rates to nickel, methylchloroisothiazolinone/methylisothiazolinone, and benzophenone-3. During the same period of study, there were significant decreases in positivity rates to neomycin, fragrance mix I, formaldehyde, thiuram mix, cinnamic aldehyde, propylene glycol, epoxy resin, diazolidinyl urea, amidoamine, ethylenediamine, benzocaine, p-tert-butylphenol formaldehyde resin, dimethylol dimethyl hydantoin, cocamidopropyl betaine, glutaraldehyde, mercaptobenzothiazole, tosylamide formaldehyde resin, budesonide, disperse blue 106, mercapto mix, and chloroxylenol. Twenty-four percent (1221) had a relevant positive reaction to a non-NACDG supplementary allergen; and 180 of these reactions were occupationally relevant. ConclusionsPeriodic analysis, surveillance, and publication of multicenter study data sets document trends in allergen reactivity incidence assessed in the patch test clinic setting and provide information on new allergens of relevance.


Dermatitis | 2008

North American Contact Dermatitis Group patch-test results, 2003-2004 study period

Erin M. Warshaw; Donald V. Belsito; Vincent A. DeLeo; Joseph F. Fowler; Howard I. Maibach; James G. Marks; C. G. Toby Mathias; Melanie D. Pratt; Robert L. Rietschel; Denis Sasseville; Frances J. Storrs; James S. Taylor; Kathryn A. Zug

Background: Allergic contact dermatitis is a significant cause of both occupational and non‐occupational skin disease. Patch testing is an important diagnostic tool for the determination of responsible allergens. Objective: This study reports the results of patch testing by the North American Contact Dermatitis Group from January 1, 2003, to December 31, 2004. Methods: At 13 centers in North America, patients were tested with the same screening series of 65 allergens, with a standardized patch‐testing technique. Data were recorded on standardized forms and manually verified and entered. Descriptive frequencies were calculated, and trends were analyzed with chi‐square statistics. Results: A total of 5,148 patients were tested. Of these, 3,432 (66.7%) had at least one positive reaction, 2,284 (44.4%) were ultimately determined to have primary allergic contact dermatitis, and 676 (13.1%) had occupation‐related skin disease. There were 9,762 positive allergic reactions. Compared to the previous reporting period (2001‐2002), allergies to nickel, budesonide, mercaptobenzothiazole, and paraben mix were at least 1.12 times more common (all p values < .03). Compared with the previous 8 years (1994‐2002), only the prevalence rates of allergies to nickel and budesonide were statistically significantly higher (p values < .003). Conclusion: Allergic contact dermatitis from nickel and budesonide may be increasing in North America. These results again underscore the value of patch‐testing with many allergens.


American Journal of Contact Dermatitis | 1996

Sesquiterpene lactone allergy

Erin M. Warshaw; Kathryn A. Zug

Sesquiterpene lactones are a large, diverse group of chemicals found in several plant families that cause allergic contact dermatitis. The biological, botanical, allergenic, and structural significance of sesquiterpene lactones is explored as well as the clinical characteristics of cutaneous reactions. The association with UV-light sensitivity and proposed mechanisms for this relationship as well as new developments in patch test methods and treatment are reviewed.


Dermatitis | 2014

Patch testing in children from 2005 to 2012: Results from the North American contact dermatitis group

Kathryn A. Zug; Anh Khoa Pham; Donald V. Belsito; Joel G. DeKoven; Vincent A. DeLeo; Joseph F. Fowler; Anthony F. Fransway; Howard I. Maibach; James G. Marks; C. G. Toby Mathias; Melanie D. Pratt; Denis Sasseville; Frances J. Storrs; James S. Taylor; Erin M. Warshaw; Matthew J. Zirwas

BackgroundAllergic contact dermatitis is common in children. Epicutaneous patch testing is an important tool for identifying responsible allergens. ObjectiveThe objective of this study was to provide the patch test results from children (aged ⩽18 years) examined by the North American Contact Dermatitis Group from 2005 to 2012. MethodsThis is a retrospective analysis of children patch-tested with the North American Contact Dermatitis Group 65- or 70-allergen series. Frequencies and counts were compared with previously published data (2001–2004) using &khgr;2 statistics. ConclusionsA total of 883 children were tested during the study period. A percentage of 62.3% had ≥1 positive patch test and 56.7% had ≥1 relevant positive patch test. Frequencies of positive patch test and relevant positive patch test reaction were highest with nickel sulfate (28.1/25.6), cobalt chloride (12.3/9.1), neomycin sulfate (7.1/6.6), balsam of Peru (5.7/5.5), and lanolin alcohol 50% petrolatum vehicle (5.5/5.1). The ≥1 positive patch test and ≥1 relevant positive patch test in the children did not differ significantly from adults (≥19 years) or from previously tested children (2001–2004). The percentage of clinically relevant positive patch tests for 27 allergens differed significantly between the children and adults. A total of 23.6% of children had a relevant positive reaction to at least 1 supplemental allergen. Differences in positive patch test and relevant positive patch test frequencies between children and adults as well as test periods confirm the importance of reporting periodic updates of patch testing in children to enhance clinicians’ vigilance to clinically important allergens.


Dermatitis | 2008

Detection of nickel sensitivity has increased in North American patch-test patients.

Robert L. Rietschel; Joseph F. Fowler; Warshaw Em; Donald V. Belsito; Vincent DeLeo; Howard I. Maibach; James G. Marks; Mathias Cg; Melanie D. Pratt; Denis Sasseville; Storrs Fj; James S. Taylor; Kathryn A. Zug

Background: Nickel allergy has been studied by contact dermatitis groups around the world, and the frequency of nickel sensitivity has been reported to be decreasing in some populations. Objective: To review the prevalence of nickel allergy as observed by the North American Contact Dermatitis Group from 1992 to 2004. Methods: The computer database of the North American Contact Dermatitis Group was used to examine the prevalence of nickel allergy over the study period and to analyze it by time, sex, and age. Results: From 1992 to 2004, 25,626 patients were patch‐tested. The percentage of women tested was fairly constant (61.4‐66.3%). A steady increase in nickel sensitivity was seen from 1992 to 2004. Subgroup analysis did not identify a population with declining nickel allergy. Conclusions: Nickel allergy continues to increase in younger and older men and women patch‐tested in North America.


Journal of The American Academy of Dermatology | 2009

Phototherapy for cutaneous T-cell lymphoma: online survey and literature review.

Joi B. Carter; Kathryn A. Zug

BACKGROUND Phototherapy modalities are frequently used in the treatment of patch and plaque mycosis fungoides (MF), but consensus recommendations on treatment regimens are variable. OBJECTIVE We sought to investigate current practice variation in patch and plaque MF phototherapy treatment and review the relevant literature. METHODS We conducted a cross-sectional online survey of International Society of Cutaneous Lymphomas members and literature review. RESULTS Survey response rate was 29%. Psoralen plus ultraviolet (UV) A (PUVA) and narrowband UVB were the most common phototherapy modalities used for patch and plaque MF treatment, with a predilection for PUVA in cases of more extensive disease and increasing skin phototype. For phototherapy treatment regimens, survey and literature results support: (1) narrowband UVB 3 times per week in the initial clearing regimen continued until clearance; and (2) PUVA 2 to 3 times per week in the initial clearing regimen, continued until clearance. Maintenance therapy regimens for narrowband UVB and PUVA varied widely from no additional treatment to one treatment per week for 5 years or more. There is not evidence to show whether phototherapy can prevent relapse or prolong disease-free interval. LIMITATIONS Small survey size of specialty interest group and limited response rate are limitations. CONCLUSIONS Although phototherapy initial clearing regimens for MF are generally consistent, variability and lack of consensus remain in the duration and frequency of maintenance therapy.

Collaboration


Dive into the Kathryn A. Zug's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

James G. Marks

Cosmetic Ingredient Review

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Melanie D. Pratt

Pennsylvania State University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Vincent A. DeLeo

University of Southern California

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge